BeyondSpring (NASDAQ:BYSI) Stock Price Down 1% – Should You Sell?

Shares of BeyondSpring Inc. (NASDAQ:BYSI) dropped 1% on Tuesday . The company traded as low as $2.12 and last traded at $2.12. Approximately 16,276 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 91,642 shares. The stock had previously closed at $2.14.

BeyondSpring Price Performance

The business has a 50-day moving average price of $2.21 and a two-hundred day moving average price of $2.28.

Institutional Trading of BeyondSpring

An institutional investor recently bought a new position in BeyondSpring stock. SG Americas Securities LLC purchased a new position in BeyondSpring Inc. (NASDAQ:BYSI) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 17,539 shares of the company’s stock, valued at approximately $63,000. 40.29% of the stock is currently owned by institutional investors.

BeyondSpring Company Profile

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.